3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Urogenital Neoplasms
1
Prostatic Diseases
1
Metastatic Neuroendocrine Prostate Cancer
1
Advanced Gastroenteropancreatic Neuroendocrine Tumor
1
Interventions
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Lutetium
×
30 days
×
Clear all
No trials found.